Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2014

Jun 2, 2014

30339_dirs_2014-06-02_e239e000-861e-40bd-89ca-2c125b12d1ce.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2014-05-30

Reporting Person: LUZZI RICHARD D (Sr. VP, Human Resources)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-05-30 Common Stock M 22828.0000 $22.4850 Acquired 123623.1300 Direct
2014-05-30 Common Stock S 22828.0000 $42.1696 Disposed 100795.1300 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-05-30 Stock Option (Right to Buy) $22.4850 M 22828.0000 Disposed 2018-02-27 Common Stock (22828.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 956.4000 Indirect
Common Stock 9193.3964 Indirect

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.